VENICE SANCHEZ: Open Payments
NPI 1609004837 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 94 payments from 20 companies in 2025. Trend: 2023 $2,192 · 2024 $1,412 · 2025 $1,806
Food & beverage: $1,806
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $363 |
| ABBVIE INC. | 21 | $245 |
| Alkermes, Inc. | 11 | $228 |
| E.R. Squibb & Sons, L.L.C. | 8 | $168 |
| Indivior Inc. | 4 | $104 |
| Supernus Pharmaceuticals, Inc. | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| LivaNova USA, Inc. | 2 | $68 |
| Lundbeck LLC | 3 | $62 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, COBENFY, REXULTI, SUBLOCADE, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, HETLIOZ.
Industry payments across CA — which companies pay providers there.
